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H/M ratioAbstract Background: The spastic motor type is the most common form of cerebral palsy (CP).
Spastic equines foot is the most frequent deformity in ambulated children with CP. Shock wave
therapy on spastic muscles of the upper limb in stroke patients provided a signiﬁcant reduction
in muscle tone.
Aim: The present study aimed to investigate the efﬁciency of shock wave therapy on spastic
planter ﬂexor muscles and its relation to the gait in spastic hemiplegic cerebral palsy children.
Methods: Thirty spastic hemiplegic cerebral palsy children from both sexes participated in this
study. They were divided randomly into two groups of equal number: Group I (control) included
15 children (6 boys and 9 girls), with mean 5.83 ± 0.34 years, received the therapeutic exercises pro-
gram only. Group II (study) included 15 children (6 boys and 9 girls), with mean age
5.75 ± 0.51 years, received the same therapeutic exercises program which was given to the control
group, in addition to shock wave therapy for 1 week (3 session/week).
Results: Comparing the pre and post treatment mean values of the Hoffman reﬂex/Motor
response (H/M) ratio and gait variables, revealed statistically signiﬁcant differences in these vari-
ables in the study group.
Conclusion: The shock wave therapy is effective in the treatment of hypertonic muscles which
help those children to become more independent and participate in everyday activities.
 2015 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Cerebral palsy (CP) is a non progressive permanent neurolog-
ical disorder resulting from a lesion in the undeveloped brain.
It has an effect on motor and postural development and
grounds sensory disorders and learning disability [1]. CP
affects between 1.5 and 2.5 per 1000 live births and is thought
to be the most common cause of severe physical disability in
childhood [2,3]. The spastic motor type is the most common
form of CP [4].
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palsy children. It is characterized by hyperexcitability of the
stretch reﬂex that leads to a velocity dependent enlarge in tonic
stretch reﬂexes with exaggerated tendon jerks [5]. The contrac-
tion of the spastic muscle groups will cause skeletal deformities
that limit the patient’s activity [6]. Spastic equines foot is the
most frequent deformity in ambulated children with CP [1].
Therefore, treatment of spasticity plays a signiﬁcant role in
the management of patients with CP. Conservative interven-
tions of spasticity may include passive stretching [7,8], serial
plastering [9,10], splints [11,12], pharmacologic treatment
[13–16], and botulinum toxin [17–21].
Shock waves are deﬁned as a series of single sonic pulses
with high peak pressure (100 MPa), fast pressure rise
(<10 ns) and short duration (10 ls). Different studies and clin-
ical experiments have established the value of shock waves in
the treatment of tendinitis calcarea of the shoulder [22,23], epi-
condylitis [24], plantar fascitis [25], and several tendon dis-
eases, particularly in athletes [26].
A single, active treatment of shock wave therapy on spastic
muscles of the upper limb in stroke patients provided a signif-
icant reduction in muscle tone. This effect lasted up to
12 weeks after therapy with a particular signiﬁcant effect on
the ﬁnger ﬂexors muscle tone [27].
This study aimed to investigate the efﬁciency of shock wave
therapy on spastic planter ﬂexor muscles and its relation to the
gait in spastic hemiplegic cerebral palsy children.2. Subjects and methods
2.1. Subjects
Thirty spastic hemiplegic cerebral palsy children from both
sexes participated in this study. They were recruited from the
outpatient clinic of the Faculty of Physical Therapy, Cairo
University, Abu El Rich Hospital and the Institute of Neuro-
motor System-Imbaba in the period from January to August
2014. Their age ranged from 5 to 7 years old. They were
divided randomly into two groups of equal number: Group I
(control) included 15 children (6 boys and 9 girls), with mean
5.83 ± 0.34 years, received the therapeutic exercises program
only. Group II (study) included 15 children (6 boys and 9
girls), with mean age 5.75 ± 0.51 years, received the same ther-
apeutic exercises program which was given to the control
group, in addition to shock wave therapy for 1 week (3 ses-
sion/week).
The subjects were selected according to the following
criteria:
1. Spasticity grades ranged from 1 to 2 according to modiﬁed
Ashwarth scale [28,29].
2. IQ level not less than 70% which is the borderline in
Wechsler’s intelligence classiﬁcation scale [30] in order to
understand and follow orders.
3. All subjects were free from any ﬁxed deformity of both
lower limbs.
4. All subjects were able to stand with support.
5. All subjects did not have visual or hearing defects.
The study was approved by an Ethics Committee of the
Cairo University. Child’s parents were provided with aVolunteer Information Sheet and written consent informing
them about the purpose of the study, its beneﬁts and inherent
risks and their committee with regard to time and money.
2.2. Instrumentations
2.2.1. For evaluation
2.2.1.1. Modiﬁed Ashwarth scale. Computerized electromyogra-
phy (EMG) apparatus: Neuroscreen plus version 1.59 pro-
duced by Toennies, a division of Erich Jaeger GmbH,
Germany; 1998 was used to determine H/M ratio.
2.2.1.2. 3D gait analysis system
Data were collected through the use of: Opto-electronic
motion analysis system with a force plate unit which was used
to measure movements or excursions of the ankle joint.
2.2.2. For treatment
The control group received the therapeutic exercises program
only.
The study group received the same therapeutic exercises
program which was given to the control group, in addition
to shock wave therapy for 1 week (3 sessions/week).
2.2.2.1. Shock wave instrumentation. Extracorporeal shock
wave therapy (ESWT) was applied by using the Orthospec
(Medispec Ltd, Germantown, MD) portable ESWT device
that is approved for distribution and is used in the United
States by the FDA. It is connected to electrical main supply
115/230 V, single phase 60/50 Hz and 10/5A was used for
creating therapeutic shockwaves. The portable shockwave gen-
erator targets the shockwaves to a 35 mm diameter therapy
zone that enables shockwaves of sufﬁcient energy to be deliv-
ered to the tissues in a single therapeutic session.
2.3. Methods and procedures
H/M ratio and gait measurements were evaluated for each sub-
ject before and at the 4th week after shock wave treatment.
2.3.1. For evaluation
2.3.1.1. Spasticity evaluation. Modiﬁed Ashworth scale was
used [28,29]. The degree of spasticity was evaluated by passive
movement for both limbs while the child was completely
relaxed, lying supine on a mat with the head in mid position.
The test was repeated 3 times and the mean record was taken
to refer accurately to the degree of spasticity to select CP chil-
dren having 1,2 grades.
2.3.1.2. H/M ratio measurement. This measurement was held in
a quiet room to avoid any changes in the reﬂex value. It was
obtained from triceps soleus muscles [31].
Setting up the child for recording:
 Sites of stimulating and recording electrodes were cleaned
by rubbing the skin using alcohol.
 The procedure was repeated until the skin became slightly
red to ensure removing of the degenerated cells and lower-
ing the skin resistance.
 Precautions were taken to avoid irritation especially at the
stimulating site.
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explained to the child’s parents, the child’s conﬁdence and
ﬁned goal friendship were gain.
Electrode placement:
 The child was located in prone position comfortably on the
examining table.
 The child’ head was kept in mid position to avoid elicitation
of any primitive reﬂex, which may alter the distribution of
muscle tone over the child’s body during recording.
 The feet were off the table with a pillow placed under the
ankle, so that the ankles were placed in a relaxed position.
 Recording was conducted from the soleus muscle as
follows: the negative electrode was placed along the
mid-dorsal line of the lower leg, 2 cm below the point of
separation of the gastrocnemius and secured by adhesive
plaster. The other positive electrode was placed distal to
the active electrode in a straight line over the tendoachillis
and secured by adhesive plaster. The earth electrode was
placed between the stimulating and recording electrodes.
The stimulating electrode was placed over the tibial nerve
just medial to the midpoint of the knee crease in the popli-
teal fossa.
 The stimulus duration was 1 ms, which stimulates the affer-
ent a nerve ﬁbers and evokes a stable H-reﬂex.
 Stimulation was at a rate of once every 3 s to avoid blocking
response and allow full recording of the reﬂex response.
 After setting up the child properly on the table and ade-
quately ﬁtting the electrodes in the previously described
position, nerve stimulating was conducted by using EMG
stimulator.
 The maximal amplitude of H-reﬂex is often obtained with
low intensity. With gradual increase of the stimulus inten-
sity, the M-response amplitude was gradually increased
while the H-reﬂex amplitude was gradually decreased. The
H/M ratio was calculated as each value is a mean of three
consecutive values of both H-reﬂex and M-response.
2.3.1.3. 3D gait analysis. Different gait parameters were evalu-
ated [32]. Preparing the system including the following
procedures:
A – Setup:
Camera placement:
The three cameras which were used in capturing the patient
motion were arranged on the affected side of the 8 m long
walkway with three cameras on the affected side. The patient
stood midway on the walkway, while the height of the cameras
was 1.5 to 2 m.
B – Calibration:
Calibration of the camera system:
The calibration was done as follows:
1- The reference structure was placed in the middle of the
measurement volume with the X-axis in the walking
direction.
2- Q-Trac calibration was started with the new calibration
command.
3- The therapist put the L-shape wand kit on the force plat-
form and standing at either side of the walkway mea-
surement volume. He grasped the T-shape calibrationwand in downward direction, vertically moving it in all
three directions (X, Y, Z), so that the measurement
points were distributed over the entire measurement
volume.
4- The wand movement sequence was done as follows:
It was started by having the wand positioned in Z direction
and was moved around in the entire measurement volume.
Both lower and upper parts of the volume were covered. Then,
the entire volume was covered in X direction and ﬁnally the
same thing was done with the wand directed in the Y direction.
It was stressed that the calibration volume fully matched the
volume of the motion measured. It took 20–30 s to complete
the calibration sequence.
Calibration of the force plate form:
Four reﬂective markers were placed to each corner of the
force plate then they were captured for ﬁve seconds. The force
plate was captured to synchronize the kinetic data obtained
from the force plate with the kinematic data obtained from
the cameras.
C – Capture:
Capture or the measurement phase started, which included
subject data (name, age, weight and height) and marker setup.
Skin marker setup:
Before starting capturing, each child was asked to take off
his/her clothes except the underwear, the reﬂected dots were
ﬁxed to the child’s skin by certain sticky material on the spe-
ciﬁc standard bony landmarks (greater trochanter, suprapatel-
lar, knee joint line, tibial tuberosity, lateral malleolus, toe and
heel).
Measurements:
Actual measurements were performed according to the fol-
lowing procedures:
- Before starting the walk on the recording procedure all help
was given to the child to get familiar with the walking and
gain his self conﬁdence. It was making sense that the child
was not distracted by anything in the room, which may
change his/her motion pattern.
- Each child was asked to start walking from a position far
enough away from the measurement volume to reach a nat-
ural continuous walking pattern once he/she entered the
measurement volume when he/she heard the alarm.
- Each child walked at self-selected walking speed along the
walkway.
- Each child was allowed several practice trials along a walk-
way at a self-selected pace to feel comfortable with proce-
dure and to strike the force plate without changing his or
her gait.
- The child was allowed to continue walking several meters
after the measurement volume. Data collection started just
before the patient entered the measurement volume and
after it, for a few seconds. It was necessary to make sure
that relevant data were collected accurately.
- All entire gait cycles were captured within the volume, as
the data required for an entire gait cycle were from the ﬁrst
initial contact of one foot to the second toe-off of the other
foot.
- The data were then saved to be analyzed later on.
D – Import:
The data processing included two main steps:
Table 1 Pre and post treatment mean values for H/M ratio in
control and study groups.
Group Mean ± SD MD t-Value P value
Pre Post
Control 4.00 ± 1.20 3.99 ± 1.20 0.01 1.00 0.33
Study 3.75 ± 1.08 1.95 ± 0.60 1.80 11.97 0.00*
MD, mean differences; Pre, pretreatment; Post, post treatment.
* Signiﬁcant.
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each by their position on the bony landmarks.
- Selection of one complete gait cycle and export of this selec-
tion to the analysis ﬁle were performed.
E – Export:
It is the transfer of the selected gait cycle of the evaluated
patient to the TSV ﬁle for analysis and obtaining of the desired
data.
F – Analysis:
Each subject’s data menu was displayed and all relevant
data were entered (name, age, sex, weight and height). Markers
used for the calculations were then identiﬁed. The calculations
were initiated with the Run button. When the calculations
were completed, the results were displayed showing the calcu-
lated global gait parameters. The gait cycle events were indi-
cated as blue and red lines in the lower part of the graphs.
There was a time cursor to simplify the interpretation of the
graphs.
2.3.2. For treatment
2.3.2.1. The designed therapeutic exercises program used for the
control and study groups included the following.
1. Changing position exercises from prone to standing and
from supine to standing position which enabled the child
to go within the normal sequence of movement up to
standing position.
2. Kneeling and half kneeling on the mat to improve bal-
ance by ﬁxing of the child’s legs in creeping position.
3. Manual standing on the mat, grasping the child around
his knees.
4. Manual standing on the mat with step forward and step
backward grasping the child around both knees.
5. Standing on one limb on the mat then standing on the
other.
6. Balance, equilibrium and protective exercises from
standing on the mat by slightly pushing the child for-
ward, backward and laterally to increase standing bal-
ance. Also the use of balance board and medical ball
is useful to improve equilibrium, protective and righting
reactions.
7. Strengthening exercises of the weak muscles like dorsi-
ﬂexors using manual resistive exercises.
8. Stoop and recovery exercises from standing position.
9. Squatting to standing exercise.
10. Gait training exercise.
2.3.2.2. Shock wave therapy. The protocol of shock wave stim-
ulation was modiﬁed from Amelio and Manganotti and Vidal
et al. to be 2000 shock of ESWT given as 3 sessions at intervals
of one week (700/session), 0.32 mJ/mm2. Children were treated
in sitting position with their affected leg supported by leg rest.
The pressure pulses were focused in the hypertonic muscles of
the lower limb: shots were used to treat gastrocnemius muscles
and soleus muscles mainly in the middle of the belly [33,34].
2.4. Statistical analysis
The mean value and standard deviation were calculated for
each variable measured during this study. Paired t-tests werecalculated for each variable measured during the study. Note
that the paired t-test provides a hypothesis test of the difference
between population means for a pair of random samples. We
used level of signiﬁcance <0.05.
3. Results
3.1. H/M ratio measurements
Comparing the pre and post treatment mean values of H/M
ratio in the control group indicated no signiﬁcant difference
as p> 0.05. Comparing the pre and post treatment mean val-
ues of H/M ratio in the study group revealed a statistically sig-
niﬁcant difference as p< 0.05 (Table 1).
3.2. Gait measurements
3.2.1. Speed, cadence, stride length, single limb support and
double limb support
Comparing the pre and post treatment mean values of speed,
cadence, stride length, single limb support and double limb
support variables in the control group indicated no signiﬁcant
differences as p> 0.05. Comparing the pre and post treatment
mean values of speed, cadence, stride length, single limb support
and double limb support variables in the study group revealed
statistically signiﬁcant differences as p< 0.05 (Table 2).
3.2.2. Ankle dorsiﬂexion in gait cycle
Comparing the pre and post treatment mean values of ankle
dorsiﬂexion at initial contact and at mid stance in the control
group indicated no signiﬁcant difference as p> 0.05. Compar-
ing the pre and post treatment mean values of ankle dorsiﬂexion
at initial contact and at mid stance in the study group revealed
statistically signiﬁcant differences as p< 0.05 (Table 3).
Comparing the pre and post treatment mean values of maxi-
mum ankle dorsiﬂexion in stance phase and at mid swing in
the control group indicated no signiﬁcant difference as
p> 0.05. Comparing the pre and post treatment mean values
of maximum ankle dorsiﬂexion in stance phase and at mid
swing in the study group revealed statistically signiﬁcant differ-
ences as p< 0.05 (Table 3).
4. Discussion
This study was conducted to investigate the efﬁciency of
shock wave therapy on spastic planter ﬂexor muscles and its
relation to the gait in spastic hemiplegic cerebral palsy chil-
dren. The age of children included in this study ranged from
Table 2 Pre and post treatment mean values for speed, cadence, stride length, single limb support and double limb support in control
and study groups.
Item Group Mean ± SD MD t-Value P value
Pre Post
SP Control 0.68 ± 0.02 0.68 ± 0.02 0.00 1.47 0.16
Study 0.67 ± 0.04 0.90 ± 0.06 0.23 13.35 0.00*
CA Control 119.60 ± 2.75 119.40 ± 2.77 0.20 1.87 0.08
Study 118.20 ± 2.33 117 ± 2.20 1.20 6.00 0.00*
SL Control 0.72 ± 0.45 0.73 ± 0.44 0.00 0.56 0.58
Study 0.70 ± 0.02 0.96 ± 0.05 0.25 21.27 0.00*
SLS Control 0.36 ± 0.13 0.36 ± 0.14 0.00 1.87 0.82
Study 0.36 ± 0.12 0.40 ± 0.20 0.03 12.67 0.00*
DLS Control 0.27 ± 0.04 0.27 ± 0.04 0.001 1.47 0.16
Study 0.26 ± 0.04 0.21 ± 0.04 0.049 16.43 0.00*
MD, mean differences; Pre, pretreatment; Post, post treatment; SP, speed; CA, cadence; SL, stride length; SLS, single limb support; DSL,
double limb support.
* Signiﬁcant.
Table 3 Ankle dorsiﬂexion in gait cycle.
Item Group Mean ± SD MD t-Value P value
Pre Post
ADTC Control 3.53 ± 1.51 3.33 ± 1.72 0.20 1.87 0.82
Study 3.87 ± 1.85 7.20 ± 1.78 11.07 14.58 0.00*
ADMS Control 5.53 ± 1.81 5.67 ± 2.02 0.13 1.67 0.16
Study 5.13 ± 2.20 12.13 ± 2.42 7.00 27.11 0.00*
MADST Control 10.80 ± 2.08 11.00 ± 2.00 0.20 1.87 0.82
Study 9.53 ± 1.81 16.20 ± 1.82 6.67 20.92 0.00*
MADSW Control 2.47 ± 3.11 2.27 ± 3.24 0.20 1.87 0.82
Study 3.93 ± 3.10 7.00 ± 1.36 10.93 18.30 0.00*
MD, mean differences; Pre, pretreatment; Post, post treatment; ADTC, ankle dorsiﬂexion at initial contact; ADMS, ankle dorsiﬂexion at mid
stance; MADST, maximum ankle dorsiﬂexion in stance phase; MADSW, maximum ankle dorsiﬂexion at midswing.
* Signiﬁcant.
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The results of this study showed a signiﬁcant reduction in
muscle tone for the study group which come in agreement
with Vidal et al., who stated that there was a signiﬁcant
reduction in muscle tone in a spastic cerebral palsy patient
treated with rESWT and this reduction lasted up to 2 months
after treatment [34]. It also comes in agreement with Amelio
and Manganotti who reported that the use of a single active
treatment of shock wave therapy for the spastic muscles of
the children with cerebral palsy produced a signiﬁcant reduc-
tion in muscle tone [27,33]. The results of this study also
showed that there was a signiﬁcant improvement in speed,
cadence, stride length, single and double limb supports and
ankle dorsiﬂexion during gait cycle. These results come in
agreement with Amelio and Manganotti who suggested that
reduction of the spastic plantar ﬂexor muscles increases the
plantar surface area on the affected side in spastic cerebral
palsy children [33]. Manganotti and Amelio noted that there
was a signiﬁcant improvement in passive range of motion of
the wrist extensor in patients affected by stroke who were
treated using a single, active treatment of shock wave therapy
[27]. Little information is available about the use of shock
wave therapy on spastic muscle. Improvements detected in
the study group using shock wave therapy may be attributed
to non-enzymatic [35] and enzymatic nitric oxide (NO)synthesis [36–38]. NO is involved in neuromuscular junction
formation in the peripheral nervous system [39] and in
important physiological functions of the CNS, including
neurotransmission, memory and synaptic plasticity [40]. NO
synthesis has been suggested as an important mechanism
to explain the effectiveness of shock waves in the anti-
inﬂammatory treatment of different tendon diseases [36–38].
A direct effect of shock waves on ﬁbrosis and on the rheolog-
ical properties of the chronic hypertonic muscles in CP should
be considered together with the documented therapeutic effect
on bone and tendon diseases [33]. In addition, we might
consider possible thixotropy effects of shock waves on tissues
and vessels of the treated muscles [36,37]. The effect of
mechanical stimuli of shock waves on the muscle ﬁbers next
to the tendon cannot be excluded [41]. Continuous or inter-
mittent tendon pressure can decrease the spinal excitability.5. Conclusion
It may be concluded that the shock wave therapy is effective in
the treatment of hypertonic muscles which help those children
to become more independent and participate in everyday
activities. More researches with larger sample sizes are
recommended.
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